Quick Answer
Cellebrite DI Ltd. reported Stockholders Equity of $484.32 million for fiscal year 2025.
Cellebrite DI Ltd. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $484.32M | +44.1% |
| 2024 | $336.02M | +882.2% |
| 2023 | $34.21M | -53.7% |
| 2022 | $73.86M | +200.7% |
| 2021 | -$73.35M | -215.0% |
| 2020 | $63.80M | +8.5% |
| 2019 | $58.83M | -15.0% |
| 2018 | $69.22M | — |
- Cellebrite DI Ltd. showed an increase of +44.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, Cellebrite DI Ltd.’s stockholders equity has grown by 599.7% (from $69.22 million to $484.32 million).
- The most recent figure is from Cellebrite DI Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: